KAIROS PHARMA, LTD. (KAPA) Operating income 2023–2025
KAIROS PHARMA, LTD. (KAPA) annual operating income history from SEC filings — each fiscal year as reported.
-$5.6MFY2025 · since FY2023: -$1.7M → -$5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.6M | -137.8% |
| FY2024 | -$2.3M | -36.7% |
| FY2023 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice